Inactive Ingredient Disclosure Expansion In House User Fee Bill Poised For Changes

Fred Upton discusses House user fee bill
Rep. Fred Upton, R-MI, debates the inactive ingredient provision in the House user fee reauthorization bill. • Source: screenshot

More from Generics

More from Biosimilars & Generics